MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

Merck Sharp & Dohme (MSD) has agreed to acquire Cidara Therapeutics in a transaction valued at approximately $9.2 billion, following encouraging results from the company’s phase 2b trial of its lead ...

The Ministry of Social Development’s Te Pae Tawhiti transformation has moved fully into its delivery phase with refreshed management and governance structures to ensure effective oversight and risk ...

Pharmaceutical giant MSD is slashing $3bn (€2.59bn) from its annual spending as part of global job cut but said it will not be closing any of its Irish sites. Pharmaceutical giant MSD is slashing $3bn ...

MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured cancer drug Keytruda, the best-selling medicine in the world. The drugmaker ...

CASE, PLEASE CALL THAT POLICE TIP LINE. LOUISVILLE’S MSD BOARD HAS APPROVED A WASTEWATER RATE INCREASE WHICH WILL AFFECT RESIDENTS IN JEFFERSON AND OLDHAM COUNTIES. SO HOW MUCH ARE WE TALKING ABOUT?

LOUISVILLE, Ky. (WDRB) -- The Louisville Metropolitan Sewer District has all 16 of its flood pump stations running right now as the Ohio River and Beargrass Creek continue to rise in the city. MSD ...

Eastdil Secured hired BDT & MSD Partners to advise the firm on potential strategic partnerships and growth initiatives, according to a memo seen by Bloomberg News. Eastdil said it’s tapping BDT & MSD ...

Hyderabad: US pharma giant Merck & Co Inc, which does business as Merck Sharp & Dohme (MSD) outside the United States and Canada, opened its first technology centre in India at Hyderabad this week, ...

Merck & Co (MSD) has entered an exclusive global licence agreement with China-based Hansoh Pharma for a preclinical oral small molecule glucagon-like peptide 1 receptor agonist (GLP-1RA) as it eyes ...